skip to main
|
skip to sidebar
Blog Archives: Nov 2004 - present
Special items: Ovarian Cancer and Us blog best viewed in Firefox
Cancer Network
....This article will address changes in CINV guidelines over the past 5
years and provide updates on recently approved agents and agents that
are expected to be approved, based on published phase III trials. It
will also explore other factors affecting optimal CINV control,
including the role of patient-related risk factors and the role of
physician adherence to antiemetic guidelines in reducing the residual
risk of CINV.....
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.